- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.59 Å
- Oligo State
- hetero-3-3-mer
- Ligands
- None
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH
- Citation
- Mima, M. et al., Structural design of the anti-TNF alpha therapeutic NANOBODY® compound, ozoralizumab, to support its potent and sustained clinical efficacy. Biochem.Biophys.Res.Commun. (2024)
- Release Date
- 2024-09-04
- Peptides
- Tumor necrosis factor: ACE
TNF30:VHH: BDF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
GC
IE
KB
HD
JF
L